Navigating New Horizons: Evolutions of MASH Care

Metabolic-associated steatohepatitis (MASH) is an urgent and growing global health concern, requiring a multidisciplinary approach to diagnosis and treatment. In this informative session, Jordan Mayberry, MPAS, PA-C, from UT Southwestern’s Hepatology Clinic in Dallas, Texas, explores the latest advancements in MASH care, including new diagnostic criteria, risk assessment, and best practices for managing patients with metabolic dysfunction-associated steatotic liver disease (MASLD).